Carisma Therapeutics Inc. (CARM)
NASDAQ: CARM
· Real-Time Price · USD
0.45
-0.05 (-10.41%)
At close: Jun 20, 2025, 3:59 PM
Carisma Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.73M | 3.65M | 3.38M | 9.2M | 3.4M | 4.29M | 3.83M | 3.56M | 3.24M | 3.73M | 2.58M | 2.7M | 822K | 20M | n/a | 2.23M | 4.31M |
Cost of Revenue | 1.54M | 669K | n/a | 255K | 1.69M | 2.08M | 695K | 715K | 705K | 18.08M | 15.56M | 3K | 10K | 11K | 10K | 8.01M | 8.01M |
Gross Profit | 3.73M | 2.98M | 3.38M | 8.94M | 1.7M | 2.21M | 3.13M | 2.85M | 2.54M | -14.35M | -12.98M | 2.7M | 812K | 19.99M | -10K | -5.78M | -3.7M |
Operating Income | -9.33M | -17.86M | -13.14M | -11.67M | -19.51M | -22.45M | -22.34M | -20.96M | -22.97M | -15.32M | -16.75M | -13.93M | -10.16M | 4.36M | -13.67M | -11.8M | -7.06M |
Interest Income | n/a | 220K | n/a | n/a | n/a | 1.29M | 941K | 1.18M | 1.48M | 1.85M | 908K | n/a | 557K | n/a | n/a | n/a | n/a |
Pretax Income | -9.27M | -17.64M | -12.7M | -11.16M | -18.98M | -21.16M | -21.4M | -19.79M | -24.53M | -7.57M | -18.33M | -14.85M | -11.31M | 8.94M | 63.11M | -25.44M | -55.22M |
Net Income | -9.27M | -17.64M | -12.7M | -11.16M | -18.98M | -20.96M | -21.4M | -19.88M | -24.64M | -16.74M | -18.33M | -14.85M | -11.31M | 8.94M | 71.62M | -25.44M | -55.51M |
Selling & General & Admin | 3.91M | 7.88M | 5.2M | 5.3M | 5.45M | 5.24M | 6.62M | 6.01M | 9.57M | 971K | 3.77M | 15.59M | 8.97M | 8.6M | 8.7M | 6.8M | 5.29M |
Research & Development | 9.16M | 15.58M | 11.33M | 15.31M | 17.46M | 19.41M | 19.55M | 18.52M | 16.64M | 18.08M | 15.56M | 14.21M | 8.77M | 7.03M | 4.96M | 7.19M | 6.05M |
Other Expenses | n/a | n/a | n/a | -15.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 13.06M | 21.51M | 16.53M | 20.61M | 22.91M | 24.66M | 26.17M | 24.52M | 26.21M | 8.04M | 19.33M | 16.64M | 10.98M | 15.63M | 13.66M | 14M | 1.09M |
Interest Expense | n/a | n/a | n/a | 508K | 532K | 291K | n/a | n/a | 1.65M | n/a | n/a | 4.93M | 1.16M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 1.95M | n/a | -255K | -1.69M | -2.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.04M | 7.02M | 5.72M | n/a |
Cost & Expenses | 13.06M | 25.4M | 16.53M | 20.87M | 22.91M | 26.74M | 26.17M | 24.52M | 26.21M | 19.05M | 19.33M | 16.64M | 10.98M | 15.64M | 13.67M | 9.1M | 11.37M |
Income Tax Expense | n/a | n/a | n/a | n/a | 1.65M | -197K | -695K | 88K | 109K | 7.75M | -676K | -3.88M | 1.71M | n/a | -8.56M | n/a | 288K |
Shares Outstanding (Basic) | 41.77M | 41.46M | 41.54M | 41.54M | 40.94M | 40.39M | 40.29M | 40.26M | 12.78M | 10.14M | 40.26M | 40.26M | 9.97M | 9.97M | 9.84M | 8.77M | 7.85M |
Shares Outstanding (Diluted) | 41.77M | 41.46M | 41.54M | 41.54M | 40.94M | 40.39M | 40.29M | 40.26M | 12.78M | 10.14M | 40.26M | 40.26M | 9.97M | 9.97M | 10.05M | 8.77M | 7.85M |
EPS (Basic) | -0.22 | -0.42 | -0.31 | -0.27 | -0.46 | -0.52 | -0.53 | -0.49 | -1.93 | 1.21 | -0.46 | -1.1 | -0.32 | 0.90 | 7.28 | -2.9 | -7.07 |
EPS (Diluted) | -0.22 | -0.42 | -0.31 | -0.27 | -0.46 | -0.52 | -0.53 | -0.49 | -1.93 | 1.21 | -0.46 | -1.1 | -0.32 | 0.90 | 7.13 | -2.9 | -7.07 |
EBITDA | -8.67M | -17.19M | -12.41M | -11.41M | -17.82M | -22.37M | -21.65M | -20.25M | -22.27M | -16.54M | -16.03M | -13.69M | -9.94M | 8.95M | 63.12M | -25.41M | -55.19M |
EBIT | -9.33M | -17.64M | -13.14M | -11.67M | -19.51M | -22.45M | -22.34M | -20.96M | -22.97M | -15.32M | -16.75M | -13.93M | -10.16M | 8.94M | 63.11M | -25.44M | -55.22M |
Depreciation & Amortization | 661K | 669K | 737K | 255K | 1.69M | 2.08M | 695K | 715K | 705K | 705K | 725K | 245K | 218K | 11K | 10K | 34K | 30K |